Sex differences and similarities in atrial fibrillation epidemiology, risk factors, and mortality in community cohorts: Results from the biomarcare consortium (Biomarker for cardiovascular risk assessment in Europe)

Circulation

Volumn 136, Issue 17, 2017, Pages 1588-1597

  Magnussen, Christina ^a,b   Niiranen, Teemu J ^c,g   Ojeda, Francisco M ^a   Gianfagna, Francesco ^e,f   Blankenberg, Stefan ^a,b   Njølstad, Inger ^d   Vartiainen, Erkki ^g   Sans, Susana ^h   Pasterkamp, Gerard ⁱ   Hughes, Maria ^j   Costanzo, Simona ^e   Donati, Maria Benedetta ^e   Jousilahti, Pekka ^g   Linneberg, Allan ^k,l,m   Palosaari, Tarja ^g   De Gaetano, Giovanni ^e   Bobak, Martin ⁿ   Den Ruijter, Hester M ⁱ   Mathiesen, Ellisiv ^d   Jørgensen, Torben ^m,o,p   Söderberg, Stefan ^q   Kuulasmaa, Kari ^g   Zeller, Tanja ^a,b   Iacoviello, Licia ^e,f   Salomaa, Veikko ^g   Schnabel, Renate B ^a,b   more..

^a UNIVERSITY HEART CENTER HAMBURG   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^c BOSTON UNIVERSITY   (United States)

^d UNIVERSITY OF TROMSØ   (Norway)

^e IRCCS NEUROMED   (Italy)

^f UNIVERSITY OF INSUBRIA   (Italy)

^g NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^h Generalitat of Catalonia Travessera de les Corts   (Spain)

ⁱ UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^j QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^k Research Center for Prevention and Health   (Denmark)

^l University of Copenhagen   (Denmark)

^m UNIVERSITY OF COPENHAGEN   (Denmark)

ⁿ UNIVERSITY COLLEGE LONDON   (United Kingdom)

^o GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^p AALBORG UNIVERSITY   (Denmark)

^q UMEÅ UNIVERSITY   (Sweden)

more..

Author keywords

Atrial fibrillation; Biomarkers; Cohort studies; Epidemiology; Mortality; Risk assessment; Sex

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CHOLESTEROL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; ATRIAL FIBRILLATION; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; AGE; AGED; BLOOD; CLINICAL TRIAL; FOLLOW UP; MULTICENTER STUDY; NORWAY; SEXUAL DEVELOPMENT; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BODY MASS INDEX; CHOLESTEROL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NORWAY; RISK FACTORS; SEX CHARACTERISTICS; SEX FACTORS;

EID: 85031775684     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.117.028981     Document Type: Article

References (53)

1. Stefansdottir H, Aspelund T, Gudnason V, Arnar DO. Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections. Europace. 2011;13:1110-1117. doi: 10.1093/europace/eur132.
2. Schnabel RB, Wilde S, Wild PS, Munzel T, Blankenberg S. Atrial fibrillation: its prevalence and risk factor profile in the German general population. Dtsch Arztebl Int. 2012;109:293-299. doi: 10.3238/arz-tebl.2012.0293.
3. Brouwers FP, de Boer RA, van der Harst P, Voors AA, Gansevoort RT, Bakker SJ, Hillege HL, van Veldhuisen DJ, van Gilst WH. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. Eur Heart J. 2013;34:1424-1431. doi: 10.1093/eurheartj/eht066.
4. Lip GY, Laroche C, Boriani G, Cimaglia P, Dan GA, Santini M, Kalarus Z, Rasmussen LH, Popescu MI, Tica O, Hellum CF, Mortensen B, Tavazzi L, Maggioni A P. Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation. Europace. 2015;17:24-31. doi: 10.1093/europace/euu155.
5. Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD, Newton-Cheh C, Lubitz SA, Magnani JW, Ellinor PT, Seshadri S, Wolf PA, Vasan RS, Benjamin EJ, Levy D. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet. 2015;386:154-162. doi: 10.1016/S0140-6736(14)61774-8.
6. Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Herpen G, Stricker BH, Stijnen T, Lip GY, Witteman JC. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006;27:949-953. doi: 10.1093/eurheartj/ehi825.
7. Vermond RA, Geelhoed B, Verweij N, Tieleman RG, Van der Harst P, Hillege HL, Van Gilst WH, Van Gelder IC, Rienstra M. Incidence of atrial fibrillation and relationship with cardiovascular events, heart failure, and mortality: a community-based study from the Netherlands. J Am Coll Cardiol. 2015;66:1000-1007. doi: 10.1016/j.jacc.2015.06.1314.
8. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98:946-952.
9. Hart RG, Pearce LA, McBride R, Rothbart RM, Asinger RW. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. Stroke. 1999;30:1223-1229.
10. Huxley RR, Lopez FL, Folsom AR, Agarwal SK, Loehr LR, Soliman EZ, Maclehose R, Konety S, Alonso A. Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 2011;123:1501-1508. doi: 10.1161/CIRCULATIONAHA.110.009035.
11. Sinner MF, Stepas KA, Moser CB, Krijthe BP, Aspelund T, Sotoodehnia N, Fontes JD, Janssens AC, Kronmal RA, Magnani JW, Witteman JC, Chamberlain AM, Lubitz SA, Schnabel RB, Vasan RS, Wang TJ, Agarwal SK, McManus DD, Franco OH, Yin X, Larson MG, Burke GL, Launer LJ, Hofman A, Levy D, Gottdiener JS, Kääb S, Couper D, Harris TB, Astor BC, Ballantyne CM, Hoogeveen RC, Arai AE, Soliman EZ, Ellinor PT, Stricker BH, Gudnason V, Heckbert SR, Pencina MJ, Benjamin EJ, Alonso A. B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies. Europace. 2014;16:1426-1433. doi: 10.1093/europace/euu175.
12. Kalogeropoulos A, Georgiopoulou V, Psaty BM, Rodondi N, Smith AL, Harrison DG, Liu Y, Hoffmann U, Bauer DC, Newman AB, Kritchevsky SB, Harris TB, Butler J; Health ABC Study Investigators. Infammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study. J Am Coll Cardiol. 2010;55:2129-2137. doi: 10.1016/j.jacc.2009.12.045.
13. Zeller T, Hughes M, Tuovinen T, Schillert A, Conrads-Frank A, Ruijter Hd, Schnabel RB, Kee F, Salomaa V, Siebert U, Thorand B, Ziegler A, Breek H, Pasterkamp G, Kuulasmaa K, Koenig W, Blankenberg S. BiomarCaRE: rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countries. Eur J Epidemiol. 2014;29:777-790. doi: 10.1007/s10654-014-9952-x.
14. Evans A, Salomaa V, Kulathinal S, Asplund K, Cambien F, Ferrario M, Perola M, Peltonen L, Shields D, Tunstall-Pedoe H, Kuulasmaa K; MORGAM Project. MORGAM (an international pooling of cardiovascular cohorts). Int J Epidemiol. 2005;34:21-27. doi: 10.1093/ije/dyh327.
15. Alonso A, Krijthe BP, Aspelund T, Stepas KA, Pencina MJ, Moser CB, Sinner MF, Sotoodehnia N, Fontes JD, Janssens AC, Kronmal RA, Magnani JW, Witteman JC, Chamberlain AM, Lubitz SA, Schnabel RB, Agarwal SK, McManus DD, Ellinor PT, Larson MG, Burke GL, Launer LJ, Hofman A, Levy D, Gottdiener JS, Kääb S, Couper D, Harris TB, Soliman EZ, Stricker BH, Gudnason V, Heckbert SR, Benjamin EJ. Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc. 2013;2:e000102. doi: 10.1161/JAHA.112.000102.
16. Comparative Quantification of Health Risks. Geneva, Switzerland: World Health Organization. http://www.who.int/publications/cra/en/. Accessed January 31, 2017.
17. Blankenberg S, Zeller T, Saarela O, Havulinna AS, Kee F, Tunstall-Pedoe H, Kuulasmaa K, Yarnell J, Schnabel RB, Wild PS, Münzel TF, Lackner KJ, Tiret L, Evans A, Salomaa V; MORGAM Project. Contribution of 30 bio-markers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) bio-marker project. Circulation. 2010;121:2388-2397. doi: 10.1161/CIRCULATIONAHA.109.901413.
18. Aalen OO, Johansen S. An empirical transition matrix for non-homogeneous Markov chains based on censored observations. Scand J Statist. 1978;5:141-150.
19. Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol. 1997;145:72-80.
20. The R Project for Statistical Computing. www.R-project.org. Accessed June 30, 2017.
21. Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, Kim YH, McAnulty JH Jr, Zheng ZJ, Forouzanfar MH, Naghavi M, Mensah GA, Ezzati M, Murray CJ. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129:837-847. doi: 10.1161/CIRCULATIONAHA.113.005119.
22. Mandalenakis Z, Von Koch L, Eriksson H, Dellborg M, Caidahl K, Welin L, Rosengren A, Hansson PO. The risk of atrial fibrillation in the general male population: a lifetime follow-up of 50-year-old men. Europace. 2015;17:1018-1022. doi: 10.1093/europace/euv036.
23. Lloyd-Jones DM, Wang TJ, Leip E P, Larson MG, Levy D, Vasan RS, D'Agostino RB, Massaro JM, Beiser A, Wolf PA, Benjamin EJ. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004;110:1042-1046. doi: 10.1161/01.CIR.0000140263.20897.42.
24. Guo Y, Tian Y, Wang H, Si Q, Wang Y, Lip GYH. Prevalence, incidence, and lifetime risk of atrial fibrillation in China: new insights into the global burden of atrial fibrillation. Chest. 2015;147:109-119. doi: 10.1378/chest.14-0321.
25. Conen D, Chae CU, Glynn RJ, Tedrow UB, Everett BM, Buring JE, Albert CM. Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. JAMA. 2011;305:2080-2087. doi: 10.1001/jama.2011.659.
26. Wanahita N, Messerli FH, Bangalore S, Gami AS, Somers VK, Steinberg JS. Atrial fibrillation and obesity-results of a meta-analysis. Am Heart J. 2008;155:310-315. doi: 10.1016/j.ahj.2007.10.004.
27. Nyrnes A, Mathiesen EB, Njølstad I, Wilsgaard T, Løchen ML. Palpitations are predictive of future atrial fibrillation. An 11-year follow-up of 22,815 men and women: the Tromsø Study. Eur J Prev Cardiol. 2013;20:729-736. doi: 10.1177/2047487312446562.
28. Wang TJ, Parise H, Levy D, D'Agostino RB Sr, Wolf PA, Vasan RS, Benjamin EJ. Obesity and the risk of new-onset atrial fibrillation. JAMA. 2004;292:2471-2477. doi: 10.1001/jama.292.20.2471.
29. Frost L, Hune LJ, Vestergaard P. Overweight and obesity as risk factors for atrial fibrillation or futter: the Danish Diet, Cancer, and Health Study. Am J Med. 2005;118:489-495. doi: 10.1016/j.amjmed.2005.01.031.
30. Knuiman M, Briffa T, Divitini M, Chew D, Eikelboom J, McQuillan B, Hung J. A cohort study examination of established and emerging risk factors for atrial fibrillation: the Busselton Health Study. Eur J Epidemiol. 2014;29:181-190. doi: 10.1007/s10654-013-9875-y.
31. Aronis KN, Wang N, Phillips CL, Benjamin EJ, Marcus GM, Newman AB, Rodondi N, Satterfield S, Harris TB, Magnani JW; Health ABC study. Associations of obesity and body fat distribution with incident atrial fibrillation in the biracial health aging and body composition cohort of older adults. Am Heart J. 2015;170:498-505.e2. doi: 10.1016/j.ahj.2015.06.007.
32. Kofer T, Theriault S, Bossard M, Aeschbacher S, Bernet S, Krisai P, Blum S, Risch M, Risch L, Albert CM, Pare G, Conen D. Relationships of measured and genetically determined height with the cardiac conduction system in healthy adults. Circ Arrhythm Electrophysiol. 2017;10:e004735.
33. Abhayaratna WP, Seward JB, Appleton C P, Douglas PS, Oh JK, Tajik AJ, Tsang TS. Left atrial size: physiologic determinants and clinical applications. J Am Coll Cardiol. 2006;47:2357-2363. doi: 10.1016/j.jacc.2006.02.048.
34. Chun KJ, Hwang JK, Park SJ, On YK, Kim JS, Park KM. Electrical PR interval variation predicts new occurrence of atrial fibrillation in patients with frequent premature atrial contractions. Medicine (Baltimore). 2016;95:e3249. doi: 10.1097/MD.0000000000003249.
35. Tedrow UB, Conen D, Ridker PM, Cook NR, Koplan BA, Manson JE, Buring JE, Albert CM. The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (Women's Health Study). J Am Coll Cardiol. 2010;55:2319-2327. doi: 10.1016/j.jacc.2010.02.029.
36. Hatem SN, Sanders P. Epicardial adipose tissue and atrial fibrillation. Cardiovasc Res. 2014;102:205-213. doi: 10.1093/cvr/cvu045.
37. Pathak RK, Middeldorp ME, Lau DH, Mehta AB, Mahajan R, Twomey D, Alasady M, Hanley L, Antic NA, McEvoy RD, Kalman JM, Abhayaratna W P, Sanders P. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. J Am Coll Cardiol. 2014;64:2222-2231. doi: 10.1016/j.jacc.2014.09.028.
38. Kuch B, Muscholl M, Luchner A, Döring A, Riegger GA, Schunkert H, Hense HW. Gender specific differences in left ventricular adaptation to obesity and hypertension. J Hum Hypertens. 1998;12:685-691.
39. Piro M, Della Bona R, Abbate A, Biasucci LM, Crea F. Sex-related differences in myocardial remodeling. J Am Coll Cardiol. 2010;55:1057-1065. doi: 10.1016/j.jacc.2009.09.065.
40. De Simone G, Devereux RB, Chinali M, Roman MJ, Barac A, Panza JA, Lee ET, Howard B V. Sex differences in obesity-related changes in left ventricular morphology: the Strong Heart Study. J Hypertens. 2011;29:1431-1438. doi: 10.1097/HJH.0b013e328347a093.
41. Abed HS, Wittert GA, Leong DP, Shirazi MG, Bahrami B, Middeldorp ME, Lorimer MF, Lau DH, Antic NA, Brooks AG, Abhayaratna W P, Kalman JM, Sanders P. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. JAMA. 2013;310:2050-2060. doi: 10.1001/jama.2013.280521.
42. Peters SA, Singhateh Y, Mackay D, Huxley RR, Woodward M. Total cholesterol as a risk factor for coronary heart disease and stroke in women compared with men: a systematic review and meta-analysis. Atherosclerosis. 2016;248:123-131. doi: 10.1016/j.atherosclerosis.2016.03.016.
43. Mora S, Akinkuolie AO, Sandhu RK, Conen D, Albert CM. Paradoxical association of lipoprotein measures with incident atrial fibrillation. Circ Arrhythm Electrophysiol. 2014;7:612-619. doi: 10.1161/CIRCEP.113.001378.
44. Lopez FL, Agarwal SK, Maclehose RF, Soliman EZ, Sharrett AR, Huxley RR, Konety S, Ballantyne CM, Alonso A. Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: the atherosclerosis risk in communities study. Circ Arrhythm Electrophysiol. 2012;5:155-162. doi: 10.1161/CIRCEP.111.966804.
45. Wang TJ, Larson MG, Levy D, Leip EP, Benjamin EJ, Wilson PW, Sutherland P, Omland T, Vasan RS. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol. 2002;90:254-258.
46. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PW, Vasan RS. Impact of obesity on plasma natriuretic peptide levels. Circulation. 2004;109:594-600. doi: 10.1161/01.CIR.0000112582.16683.EA.
47. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ. 2006;332:73-78. doi: 10.1136/bmj.38678.389583.7C.
48. Peters SA, Huxley RR, Woodward M. Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775,385 individuals and 12,539 strokes. Lancet. 2014;383:1973-1980. doi: 10.1016/S0140-6736(14)60040-4.
49. Huxley RR, Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet. 2011;378:1297-1305. doi: 10.1016/S0140-6736(11)60781-2.
50. Ball J, Carrington MJ, Wood KA, Stewart S; SAFETY Investigators. Women versus men with chronic atrial fibrillation: insights from the Standard versus Atrial Fibrillation spEcific managemenT studY (SAFETY). PLoS One. 2013;8:e65795. doi: 10.1371/journal.pone.0065795.
51. Potpara TS, Marinkovic JM, Polovina MM, Stankovic GR, Seferovic PM, Ostojic MC, Lip GY. Gender-related differences in presentation, treatment and long-term outcome in patients with first-diagnosed atrial fibrillation and structurally normal heart: the Belgrade atrial fibrillation study. Int J Cardiol. 2012;161:39-44. doi: 10.1016/j.ijcard.2011.04.022.
52. Bengtson LG, Kucharska-Newton A, Wruck LM, Loehr LR, Folsom AR, Chen LY, Rosamond WD, Duval S, Lutsey PL, Stearns SC, Sueta C, Yeh HC, Fox E, Alonso A. Comparable ascertainment of newly-diagnosed atrial fibrillation using active cohort follow-up versus surveillance of Centers for Medicare and Medicaid Services in the atherosclerosis risk in communities study. PLoS One. 2014;9:e94321. doi: 10.1371/journal.pone.0094321.
53. Mikkelsen L, Phillips DE, AbouZahr C, Setel PW, de Savigny D, Lozano R, Lopez AD. A global assessment of civil registration and vital statistics systems: monitoring data quality and progress. Lancet. 2015;386:1395-1406. doi: 10.1016/S0140-6736(15)60171-4.